The functional roles of PIK3R3 in CRC, to sustain cell proliferation (and presumably tumour growth), and the mTOR pathway were both disrupted following PIK3R3 knockdown, possibly reflecting the consequences of reduced PIK3R3 levels following metformin treatment. This evidence concerns the gene PIK3R3 and colorectal carcinoma.